Skip to main content

Quark Biotech Becomes Certified Agilent Microarray Service Provider

NEW YORK, April 20 (GenomeWeb News) - Quark Biotech has become a certified microarray service provider for Agilent Technologies' platform, the company said today.


Quark's services include extracting and labeling RNA samples using Agilent's gene-expression platform for hybridization and data analysis.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.